Orion Biotechnology Canada Acquires K2Biomedical June 14, 2018 OTTAWA, June 14, 2018 (GLOBE NEWSWIRE) — Orion Biotechnology Canada Ltd., a developer of novel medicines, today announced the acquisition of K2Biomedical, a specialty pharmaceutical Read More »